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Abstract: Background. The purpose of this prospective
study was to assess the quality of life (QOL) and oral functioning
of patients with oral cancer up to 5 years after prosthodontic
rehabilitation with mandibular implant-retained overdentures.
Methods. Fifty patients who had received implants during
ablative surgery were evaluated by standardized question-
naires before and after oncological and prosthetic treatment.
Results. In 20 of 24 surviving patients, the dentures were
functional after 5 years. In these survivors, oral function
remained unchanged during this period. In the 6 patients with
concurrent comorbidity, global health and QOL had deterio-
rated, while in the patients without comorbidity, global health
and QOL were very high. Five-year survivors had a higher
global health and better oral functioning at the 1-year evalua-
tion than nonsurvivors.
Conclusion. Oral function and denture satisfaction were
high and did not change over time for survivors. Deterioration
in overall global health and QOL was associated with concur-
rent comorbidity. VC 2010 Wiley Periodicals, Inc. Head Neck
33: 831–839, 2011
Keywords: head and neck cancer; edentulous; dental implants;
dental prosthesis; quality of life
Prosthodontic rehabilitation in patients with oral can-
cer is challenging as oral functioning is hampered due to
the surgical treatment and the subsequent radiotherapy.
As a consequence of this combined treatment, wearing a
mandibular prosthesis is severely impeded due to the
changed anatomic conditions and the intolerance of the
denture-bearing mucosa to mechanical loading.1–4 A so-
lution for this problem might be to provide the patients
with an implant-retained mandibular overdenture.
Implant survival in irradiated mandibles, although gen-
erally lower than in healthy patients, has still been
shown to be relatively high in most articles shown in the
literature, and patients have reported an improved level
of oral functioning when provided with such a denture.5–
13 Also, assessment of the effect of such a treatment on
the patients’ functioning and overall quality of life
(QOL) is of the utmost importance.14–20
In healthy subjects, no clinically relevant changes
in oral functioning and patient satisfaction are to be
expected after the ﬁrst year of prosthodontic rehabili-
tation with an implant-retained overdenture.21,22 In
patients with oral cancer, it is questionable whether
this is also applicable, or whether the remaining side
effects of the oncological treatment and the impact of
having had cancer are more prominent and veil the
beneﬁcial effect of an adequate prosthodontic rehabili-
tation on oral function and QOL. Thus, the purpose
of this prospective study was to assess oral function-
ing and QOL in patients with oral cancer in whom
implants had been installed during ablative tumor
surgery, up to 5 years after prosthodontic rehabilita-
tion with implant-retained mandibular overdentures.
MATERIALS AND METHODS
Patients and Treatment. All consecutive edentulous
patients with oral cancer referred to the Head and
Neck Oncology group of the University Medical Cen-
ter Groningen between May 1998 and April 2002
were screened to be included in this study. Inclusion
criteria were edentulous upper and lower jaw, history
of prosthetic problems related to the lack of stability,
and retention of the lower denture or expected den-
ture-related problems after oncology treatment, ﬁrst
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malignancy in head and neck region (squamous cell
carcinoma of the tongue, ﬂoor of mouth, mandibular
gingiva, buccal mucosa, or oropharynx), and the need
for primary ablative surgery. The patients were
screened by an experienced maxillofacial surgeon
(G.M.R.) and prosthodontist (H.R.). It was required
that little or no improvement was to be expected from
making new dentures after oncological treatment.
Patients were offered conventional or implant-based
treatment. Fifty-three patients fulﬁlled the inclusion
criteria and 50 patients accepted the option of
implant installation during ablative surgery. Two
patients refused to have implants installed and 1
patient had never worn a prosthesis. Informed con-
sent was provided from all patients before treatment.
Tumor surgery and implant insertion were per-
formed at the University Medical Center Groningen.
All implants (3.75 mm Bra˚nemark screw implants
with a machined surface, Nobelbiocare, Gothenburg,
Sweden) were inserted during the ablative tumor sur-
gery procedure. All implants were placed in the inter-
foraminal region of the native bone of the mandible in
a 2-stage surgical procedure. A 3-month osseointegra-
tion period before abutment connection was considered
in patients not having radiotherapy after tumor sur-
gery (18 patients). If postoperative radiotherapy was
scheduled (32 patients), in general, starting within 6
weeks after surgery, the osseointegration time before
abutment connection was increased to 9 months after
surgery. All patients were treated by 1 maxillofacial
surgeon (G.R.) and 1 prosthodontist (H.R.). Details are
described in the article by Schoen et al.10
Functional Assessments and Quality of Life. Pre-
operatively, on the day of hospital admission (T0),
patients were asked to complete questionnaires regard-
ing oral functioning and QOL. The questionnaires were
administered by an investigator not involved in treat-
ment of the patients (P.S.). Similar questionnaires and
questionnaires regarding denture satisfaction and the
impact of denture-related problems on social activities
had to be completed 6 weeks (T1), 1 year (T2), and
5 years (T3) after placing the new dentures.
QOL was assessed using the core questionnaire
(Quality of Life Questionnaire-Core 30-questions
[QLQ-C30]) and head and neck module (Quality of Life
Questionnaire-Core 30 Head and Neck 35-questions
[QLQ-H&N35]) of the European Organization for
Research and Treatment of Cancer (EORTC).23 Psycho-
logical, physical, and social impact of oral disorders
was assessed using the Oral Health Impact Proﬁle
(OHIP).24 General QOL was assessed with the Linear
Analogue Self Assessment method (LASA; 1-item ver-
sion).25 Denture satisfaction was assessed using a vali-
dated questionnaire consisting of 8 separate items
focusing on the function of upper and lower dentures,
and on speciﬁc features such as aesthetics, retention,
and functional comfort.26 Overall denture satisfaction
was expressed on a 10-point rating scale (0–10); 0
being completely dissatisﬁed, to 10 being completely
satisﬁed. Subjective chewing ability was assessed using
a 9-item questionnaire on which the patient could rate
on a 3-point scale their ability to chew different kinds
of food.27 Impact of denture problems on social activities,
such as going out, and contacting and visiting people, was
assessed with the Groningen Activity Restriction Scale
Dentistry.28
Data Analysis. The obtained data were evaluated
using SPSS (version 16.0 for Windows, SPSS, Chicago,
IL). Data are shown asmeans SD. Changes were stated
as signiﬁcant if p< .05.When comparing different groups
of patients at the same time, the Mann–Whitney test was
used. When comparing results within groups at different
times, theWilcoxon signed-rank test was applied.
RESULTS
Patients and Implants. Patient characteristics are
presented in Table 1. In total, 50 patients, 35 men
and 15 women (mean age, 61.5  11.2 years; range,
41–81 years) were included at T0.
In total, 195 implants were placed in the initial
group of 50 patients; of them, 18 patients were treated
with surgery only (72 implants) and 32 patients were
treated with radiotherapy in addition (123 implants).
During the 5-year follow-up, a total of 14 implants were
lost; 13 implants in 6 patients who received radiother-
apy (implant survival rate 89.4%) and 1 implant in a
non-irradiated patient (implant survival rate 98.6%).
At T2, 1 year after denture placement, 35 overden-
tures were in function. Twelve patients had died (48
implants), 7 before abutment connection. Two patients
had refused abutment connection (6 implants), because
they did not want any additional, nontumor-related,
surgery; and 1 patient had already lost 3 implants
before abutment connection. The results of T2 have
been published previously.10 At T3, 5 years after den-
ture placement, 26 patients were deceased. Another 4
patients who survived T3 had to be excluded from fol-
low-up due to removal of the superstructures related to
local irritation (n ¼ 2), loss of 3 implants (n ¼ 1), and
the impossibility of making a denture after ablation
because of derived anatomic limitations (n ¼ 1). Of the
remaining 20 patients with functional dentures at T3, 9
patients were irradiated (45%).
Quality of Life and Functional Assessments
European Organization for Research and Treatment of Cancer
Quality of Life Questionnaire-Core 30-Questions and Quality of Life
Questionnaire-Core 30 Head and Neck 35-Questions. The
results of the EORTC QLQ-C30 and QLQ-H&N35
questionnaires are presented in Table 2. The results
of the evaluations after 1 and 5 years are presented
for patients who survived T3 (n ¼ 20), divided into irra-
diated (RTX; n ¼ 9) and non-irradiated patients (non-
RTX; n ¼ 11). Hardly any differences between and
within the groups were found. In the total group, the
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reported global health and general health after 5 years
was lower than after 1 year (p < .05) and general QOL
tended to decrease (p ¼ .070). Weight loss had
increased in 4 years. In irradiated patients, the mouth
opening was reported more restricted and dry mouth
was more severe (only signiﬁcant after 1 year; p < .05).
Comorbidity. Based on the data in the patients’ medi-
cal histories, patients were subdivided into 2 groups
based on the comorbidity noticed at T3 (Table 3). Six
patients were identiﬁed with comorbidity, including sec-
ondary radiotherapy (after T2) in the head and neck
region (n ¼ 2), an established stroke, lung metastases,
severe lung emphysema, and a transient ischemic attack
(Table 1). When looking into detail in these patients,
global health, physical function, fatigue, and dyspnea
were signiﬁcantly worse in these patients with comorbid-
ity. QOL and global health were very high in patients
without comorbidity and remained at the same level
Table 1. Patient characteristics.
Age at diagnosis, y Sex Primary tumor Stage Total intraforaminal dose, Gy Status
57 F Mandibular gingiva T4N1 – 1 (NTR)
59 M Floor of mouth T4N2b – 1 (NTR)
77 F Tongue T3N2b 64 1 (TR)
79 M Floor of mouth T4N0 60 1 (TR)
52 F Tongue/ﬂoor of mouth T2N1 64 1 (TR)
53 M Floor of mouth T4N0 65 1 (TR)
69 M Oropharynx T2N2b 64 1 (TR)
81 M Oropharynx T3N1 30 2 (NTR)
52 F Tongue T2N1 58 2 (NTR)
61 M Mandibular gingiva T2N0 64 2 (TR)
81 F Tongue/ﬂoor of mouth T2N0 – 2 (TR)
50 M Mandibular gingiva T4N2b 61 2 (TR)
75 M Tonsil T2N0 – 3 (NTR)
64 M Floor of mouth T2N2c 59 3 (NTR)
59 M Tonsil T3N0 60 3 (NTR)
68 F Floor of mouth T2N0 – 3 (NTR)
65 M Mandibular gingiva T2N0 – 3 (NTR)
49 F Base of tongue T3N1 58 3 (NTR)
66 M Mandibular gingiva T4N2b 67 3 (NTR)
48 M Floor of mouth T4N1 55 3 (NTR)
78 F Mandibular gingiva T1N0 – 3 (NTR)
54 M Mandibular gingiva T4N1 62 3 (NTR)
70 M Mandibular gingiva T4N2b 50 3, 4 (NTR)
50 M Floor of mouth T2N1 65 3 (TR)
66 M Mandibular gingiva T4N2b 64 3 (TR)
59 M Oropharynx T4N2b 61 3 (TR)
49 F Floor of mouth T2N0 57 4
76 F Mandibular gingiva T4N0 64 4
49 M Floor of mouth T2N0 50 4 (after 1 y)
71 M Tonsil T3N1 67 4 (after 1 y)
43 M Tongue/ﬂoor of mouth T2N0 – 5
65 M Floor of mouth T2N1 70 5
43 F Tongue T1N0 – 5
55 F Tongue T2N0 – 5
77 M Tongue T1N0 – 5
56 F Floor of mouth T1N0 – 5
41 M Base of tongue T3N0 63 –
54 M Tongue T2N1 46 –
51 F Floor of mouth T1N0 61 –
64 M Mandibular gingiva T4N0 62 –
52 M Oropharynx T3N0 12 –
65 M Floor of mouth T2N0 – –
63 F Tongue T3N2c 62 –
46 M Tongue T3N0 64 –
54 M Mandibular gingiva T1N0 – –
69 M Tongue T2N0 – –
71 M Tongue T2N0 – –
72 M Tongue T2N0 – –
66 M Tongue T3N2b 66 –
80 M Tongue T2N0 – –
Abbreviations: F, female; M, male; NTR, not tumor-related; TR, tumor-related.
Notes: Patient characteristics regarding age, sex, primary tumor, staging, total interforaminal dose of radiotherapy, and status: 1: died in ﬁrst year, before prosthesis could be
made; 2: died in the ﬁrst year after delivery of prosthesis; 3: died after ﬁrst year, but before 5-year evaluation; 4: wears no prosthesis; 5: comorbidity notiﬁed at T3.
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between T2 and T3. When comparing the T1-data and T2-
data, there was a progressive decrease in general health,
global health, and cognitive function over time in patients
with comorbidity. A tendency toward a decrease in cogni-
tive function (p ¼ .078) and an increase in weight loss (p ¼
.083) with timewas also seen in patients with comorbidity.
Radiotherapy. The global health status in irradiated
patients was higher than the non-irradiated patients.
However, 5 patients with comorbidity were among the
11 non-irradiated patients, whereas there was only 1
patient with comorbidity among the 9 irradiated patients.
When excluding the patients with comorbidity, the differ-
ences in the EORTCQLQ-C30 disappeared.
At T2, the irradiated patients reported a dryer mouth,
less opening of the mouth, and more difﬁculties with
swallowing in the QLQ-H&N35 questionnaires (Table 2).
At T3, the differences between irradiated and non-irradi-
ated patients did not reach signiﬁcance, although trends
were seen toward a dryer mouth (p ¼ .095) and more
pain (p ¼ .056) in irradiated patients. When taking
comorbidity into account, we saw several differences in
the QLQ-H&N35; the irradiated patients reported a
dryer mouth, more pain (p < .05), less opening of the
mouth, more problems in speech, and more problems
related to the dentures (p¼ .059).
When comparing the irradiated patients with the
non-irradiated patients, over time, global health and
global health-related QOL tended to decrease for the
irradiated patients (p ¼ .059 and p ¼ .066).
Survivors versus Nonsurvivors. When looking ret-
rospectively into the 35 patients with functional
Table 2. EORTC QLQ-C30 and EORTC QLQ-H&N 35 questionnaires.
After 1 y After 5 y
Irradiated Non-irradiated Irradiated Non-irradiated
n ¼ 9 n ¼ 11 n ¼ 9 n ¼ 11
EORTC QLQ-C30
Global health status/quality of life 93.5  8.1 74.2  24.6* 83.3  12.5 64.4  30.5†
Physical functioning 85.9  17.5 73.3  23.5 88.9  10.0 68.5  33.3
Role functioning 90.7  14.7 77.3  31.0 88.9  18.6 72.7  38.2
Emotional functioning 94.4  16.7 87.9  22.5 91.7  15.0 79.5  28.0
Cognitive functioning 90.7  12.1 86.4  19.5 88.9  8.3 75.8  27.2
Social functioning 94.4  11.8 86.4  30.6 88.9  16.7 83.3  25.8
Fatigue 13.6  16.5 20.2  30.2 12.3  14.1 24.2  26.7
Nausea and vomiting 0.0  0.0 3.0  6.7 5.6  16.7 1.5  5.0
Pain 13.0  16.2 10.6  25.0 13.0  23.2 9.1  15.6
Dyspnea 0.0  0.0 24.2  36.8 11.1  23.6 27.3  46.7
Insomnia 3.7  11.1 9.1  15.6 3.7  11.1 9.1  15.6
Appetite loss 0.0  0.0 9.1  30.2 7.4  14.7 16.7  28.3
Constipation 3.7  11.1 0.0  0.0 3.7  11.1 3.0  10.1
Diarrhea 0.0  0.0 6.1  13.5 11.1  23.6 6.1  13.5
Financial difﬁculties 14.8  17.6 6.1  20.1 22.2  37.3 10.0  16.1
EORTC QLQ-H&N35
Pain 15.7  22.6 6.1  9.9 19.4  11.8 9.1  17.3
Swallowing 19.4  15.6 6.8  9.0* 12.7  14.2 15.8  23.4
Sensory problems 18.5  17.6 15.2  32.0 13.0  23.2 22.7  31.0
Speech problems 13.6  18.2 9.1  14.8 18.5  22.9 14.1  21.1
Trouble with social eating 22.2  19.5 12.1  25.6 21.3  28.0 20.0  28.7
Trouble with social contact 4.4  11.1 5.5  12.9 5.2  15.6 4.2  8.0
Less sexuality 16.7  28.9 14.8  32.7 18.8  30.1 25.0  34.5
Teeth 14.8  33.8 9.1  15.6 25.9  32.4 6.7  21.1
Opening mouth 44.4  28.9 9.1  21.6‡ 25.9  32.4 6.7  14.1
Dry mouth 55.6  28.9 21.2  22.5* 51.9  29.4 26.7  34.4
Sticky saliva 33.3  28.9 12.1  16.8 37.0  35.1 30.3  34.8
Coughing 14.8  17.6 27.3  25.0 14.8  17.6 15.2  22.9
Felt ill 3.7  11.1 6.1  20.1 14.8  33.8 15.2  22.9
Pain killers 22.2  44.1 45.5  52.2 22.2  44.1 18.2  40.5
Nutritional supplements 22.2  44.1 9.1  30.2 22.2  44.1 18.2  40.5
Feeding tube 0.0  0.0 0.0  0.0 0.0  0.0 18.2  40.5
Weight loss 0.0  0.0 9.1  30.2 22.2  44.1 36.4  50.5
Weight gain 11.1  33.3 27.3  46.7 0.0  0.0 9.1  30.2
Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30-questions; EORTC QLQ-H&N35, European
Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 Head and Neck 35-questions.
*Signiﬁcant difference between irradiated and non-irradiated patients at the same point in time p < .05.
†Signiﬁcant difference between 5 years after placement and one year after placement p < .05.
‡Signiﬁcant difference between irradiated and non-irradiated patients at the same point in time p < .01.
Notes: Results of the functional scales, symptom scales and single items of the EORTC QLQ-C30 and multi-item scales and single items of the EORTC QLQ-H&N 35 question-
naires for the 5 years surviving patients with a functional implant-retained overdenture, at 1 and 5 years after placement of the dentures (for irradiated and non-irradiated
patients). For the 1-year results (n ¼ 35 patients) see Schoen et al.10
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dentures at T2, there were some differences between
the 5-year survivors with functional dentures (n ¼
20) and those patients who did not make it to T3 (n ¼
12; the results are not depicted in a table in this arti-
cle). At T2, the 5-year survivors had reported a higher
global health and fewer problems with swallowing (p
< .05) than the nonsurvivors. Nonsurvivors tended to
report more pain and a lower general QOL than the
survivors (p ¼ .068).
Oral Health Impact Proﬁle, Functional Assessments,
Social Restrictions, and Denture Satisfaction. The
OHIP results are presented in Table 4, and the
results of questionnaires regarding oral func-tioning
and denture satisfaction are presented in Table 5.
Over time, there were no changes in results for the
total group, neither were differences seen between
patients with or without comorbidity.
Radiotherapy. A tendency toward more pain was
reported in the OHIP in the irradiated group (p ¼
.067) between T2 and T3. When excluding patients
with comorbidity, more differences were found
between irradiated patients and non-irradiated
patients: at T3, irradiated patients reported more
functional limitations and physical pain (p < .05)
than non-irradiated patients, a tendency was seen to-
ward more physical disability (p ¼ .081) and a higher
score in the handicap domain (p ¼ .081) in irradiated
patients. Previously, we reported that overall denture
satisfaction was higher in non-irradiated patients
than in irradiated patients at T2,
10 but in the irradi-
ated patients, denture satisfaction was also rather






Global health status/quality of life 48.6  27.6 83.3  16.3*
Physical functioning 50.0  35.5 89.5  9.3*
Role functioning 55.6  44.3 90.5  16.9
Emotional functioning 69.4  33.6 91.7  14.2
Cognitive functioning 63.9  30.6 89.3  10.5
Social functioning 69.4  28.7 92.9  14.2
Fatigue 40.7  26.0 9.5  12.2*
Nausea and vomiting 2.8  6.8 3.6  13.4
Pain 16.7  18.3 8.3  19.3
Dyspnea 61.1  49.1 2.4  8.9†
Insomnia 11.1  17.2 4.8  12.1
Appetite loss 33.3  33.3 4.8  12.1
Constipation 5.6  13.6 2.4  8.9
Diarrhea 11.1  17.2 7.1  19.3
Financial difﬁculties 16.7  18.3 15.4  32.2
Abbreviation: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 questions.
*Signiﬁcant difference between patients with and without comorbidity after 5 years p < .01.
†Signiﬁcant difference between patients with and without comorbidity after 5 years p < .05.
Notes: Results of the functional scales, symptom scales, and single items of the EORTC QLQ-C30 for patients with and without comorbidity, 5 years after placement of the
dentures.
Table 4. OHIP questionnaire.
After 1 y After 5 y
Irradiated Non-irradiated Irradiated Non-irradiated
n ¼ 9 n ¼ 11 n ¼ 9 n ¼ 11
OHIP14 12.4  10.9 6.3  8.9* 12.8  12.1 6.7  6.5
Functional limitation 12.0  6.5 6.6  5.4† 11.1  5.9 7.3  4.8
Physical pain 7.0  9.5 4.0  6.3 11.0  9.6 4.3  6.1‡
Physical disability 13.0  10.7 5.9  8.1§ 10.4  10.5 6.2  6.3
Psychological discomfort 2.1  5.3 0.8  1.9 3.4  5.8 1.0  2.0
Psychological disability 2.0  4.3 0.9  2.4 1.9  3.6 0.9  1.0
Social disability 1.3  2.5 0.8  1.8 1.3  2.7 0.9  1.3
Abbreviations: OHIP, Oral Health Impact Proﬁle.
*Signiﬁcant difference between irradiated and non-irradiated patients at the same point in time; p < .05.
†Tendency toward difference between irradiated and non-irradiated patients at the same point in time; p ¼ .056.
‡Tendency toward difference between irradiated and non-irradiated patients at the same point in time; p ¼ .067.
§Tendency toward difference between irradiated and non-irradiated patients at the same point in time; p ¼ .056.
Notes: Results of the Oral Health Impact Proﬁle (OHIP) questionnaire, at 1 and 5 years after placement of the dentures, for irradiated and non-
irradiated 5-year survivors with a functional implant-retained overdenture. For the 1-year results (n ¼ 35 patients) see Schoen et al.10
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high. On the other scales of functional assessment,
the non-irradiated patients showed better results
than the irradiated patients at T2.
10 At T3, denture
satisfaction again scored high, but denture satisfac-
tion and functional assessment showed no differences
between irradiated and non-irradiated patients. Over-
all QOL, as measured with the LASA, showed, as did
the EORTC QLQ-C30, a higher QOL for the irradi-
ated patients after 5 years (p ¼ .055), but this differ-
ence disappeared when taking comorbidity into
account.
Survivors versus Nonsurvivors. At T1, nonsurvivors
reported to be more concerned with the future func-
tioning of their dentures than the 5-year survivors (p
< .05). There tended to be more social restrictions
and chewing problems (p ¼ .095 and p ¼ .074) for
the non-survivors than for the survivors. At T2,
survivors reported less social restrictions than non-
survivors (p ¼ .059). Also, survivors tended to be
more satisﬁed with their dentures than the nonsurvi-
vors (p ¼ .087).
DISCUSSION
The surviving 20 patients with functional dentures
did not report a difference in oral function between 1
year and 5 years after prosthetic rehabilitation. The
observed deterioration in overall global health and
QOL was strongly associated with concurrent comor-
bidity in 6 patients. For patients without known
comorbidity, general QOL and global health were
very high.
No difference in oral function was reported at the
1 year and 5 year follow-ups after placement of the
prostheses. This observation is comparable to results
of studies in healthy subjects.21,22 The oral function of
the patients in this study was reasonable, but lower
than in healthy subjects.27 Still, the denture satisfac-
tion was very high. However, there was a difference
in global health, oral and social functioning, and den-
ture satisfaction between the 5-year survivors and
the nonsurvivors, indicating a ‘‘natural’’ selection of
patients. This is in agreement with the ﬁndings of
other studies,30,31 where high scores of functioning
scales and low scores on symptom items at 1-year fol-
low-up seemed to predict a high survival at 5 years.
In our study, survivors reported fewer problems with
swallowing and less restrictions in social activities.
The nonsurvivors were more concerned with
the future functioning of their dentures than the sur-
vivors. An explanation can be that the 20 patients
with a functional denture had a lower percentage of
large tumors compared to the nonsurvivors (Table 1),
thus needing less extensive surgery with less morbid-
ity. Also, among the deceased and excluded patients
at T3, a larger percentage had received radiotherapy
in comparison to the survivors, probably giving less
favorable oral conditions.
The scores of the EORTC QLQ-C30 and QLQ-
H&N35 questionnaires at T3 are comparable to the
results of other QOL studies in patients with head
and neck cancer.30–34 The patients without known
comorbidity reported high scores comparable to those
of healthy subjects. This observation indicates that
even after oncological treatment, patients still can
reach ‘‘normal’’ health levels. Furthermore, in previ-
ous studies, the question was raised whether patients
do value oral rehabilitation as essential in their life
after head and neck cancer. In one study reporting
on general QOL in patients without an implant-borne
overdenture, no difference in general QOL was found
between the patients who wore their mandibular
dentures and patients who did not.35 A review relat-
ing QOL to functional outcome also showed no
difference in QOL between patients with a
conventional dental/tissue-supported denture, an
implant-retained overdenture, and patients without
dentures.17 Most patients reported satisfactory out-
comes regardless of the type or presence of prosthetic
rehabilitation. This ﬁnding is in agreement with the
ﬁndings of Murphy et al,18 as data correlated QOL
with functional outcome and symptom burden often
fails to demonstrate a consistent relationship. The
latter authors suggested that this may be attributed
to methodological issues in the study design or the
patient’s ability to adapt to functional and symptom
control problems.
Table 5. Oral functioning and denture satisfaction.
After 1 y After 5 y
Irradiated Non-irradiated Irradiated Non-irradiated
n ¼ 9 n ¼ 11 n ¼ 9 n ¼ 11
GARS-D 2.6  4.6 1.9  3.9 3.5  5.0 2.8  5.1
Denture satisfaction 12.9  4.8 11.6  4.4 13.9  4.8 11.8  3.1
Overall denture satisfaction 8.4  1.2 8.5  1.4 8.5  1.3 8.9  1.1
Chewing/eating 7.4  7.0 3.8  4.3 6.0  6.7 4.6  4.9
LASA quality of life 81.8  18.5 69.3  24.9 87.4  9.5 65.3  28.7*
Abbreviations: GARS-D, Groningen Activity Restriction Scale Dentistry; LASA, Linear Analogue Self Assessment.
*Tendency toward difference between irradiated and non-irradiated patients at the same point in time p ¼ .055.
Notes: Results of questionnaires regarding oral functioning and denture satisfaction, at 1 and 5 years after placement of the dentures, for irradiated and non-irradiated patients
with a functional implant-retained overdenture. For the 1-year results (n ¼ 35 patients) see Schoen et al.10
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It is obvious that certain stages of disease and
cancer treatment will lead to disastrous anatomic or
physiological conditions in which oral rehabilitation
cannot be restored to a level comparable to the level
before onset of the disease. However, the patients’
ability to adapt to functional problems and to accept
the loss of some oral functions should not be under-
estimated. Another conclusion could be that vali-
dated sensitive instruments to rate the inﬂuences of
oral rehabilitation on QOL are still not available for
general application. Regarding general health-
related QOL, such validated instruments are com-
monly available.15 However, these general health-
related QOL questionnaires seem to lack the dis-
criminating ability to measure the effects of prostho-
dontic treatment on QOL in patients with oral
cancer. Efforts have been made to develop instru-
ments that might solve this problem, such as Liver-
pool Oral Rehabilitation Questionnaire, which was
developed in 2004 and has been used ever since.36–39
Also, more speciﬁc questionnaires that focus on head
and neck function, such as speech and swallowing
are currently available.40 Unfortunately, we were
not able to use such questionnaires as these ques-
tionnaires were not available at the time of inclusion
of our patients into our study.
It seems that other factors such as comorbidity
are far more important in determining the patients’
QOL being an important caution that has to be con-
sidered when interpreting the results of the ques-
tionnaires regarding general health. With a closer
look, the decrease in QOL we observed appeared to
be caused by a small group of patients with severe
comorbidity. Most patients with comorbidity were
not irradiated. When taking this comorbidity into
account, the speciﬁc head and neck module reveals
differences between the irradiated and non-irradi-
ated patients even after 5 years, which can be
related to the late effects of the radiotherapy, such
as dry mouth, less opening of the mouth, and prob-
lems with swallowing and speech. Terrell et al41
ranked comorbidity to be the second greatest predic-
tor of decreased QOL in patients with head and
neck cancer. In our study, we did not apply standard
comorbidity measures as the Adult Comorbidity
Evaluation-27, that are currently used in studies to
code and quantify comorbidity.42–44 Nevertheless, we
were able to indicate that comorbidity apparently
played a larger role in decreased QOL scores than
radiotherapy. However, 2 patients received radiother-
apy between T2 and T3 due to recurrent disease. In
the analysis, these patients were scored as non-irra-
diated (intention-to-treat procedure) and were con-
sidered as having comorbidity. This could also
explain why differences are only found in the head
and neck module when excluding patients with
comorbidity.
Implant loss was higher in patients who received
radiotherapy post–tumor surgery. This is in agree-
ment with other studies.5,7,8,11 A review reports that
the increase in the risk of implant failure in irradi-
ated patients may be up to 12 times greater; however,
the magnitude of this difference should be accepted
with caution, because studies making these compari-
sons are of poor to moderate quality.12 The failure
rate of 10.6% in irradiated bone over a period of 5
years found in our study is considered good. However,
26 patients had died and the percentage of patients
who had received postoperative radiotherapy
decreased over time among the survivors (73% at
baseline vs 54% 5 years after placement of the den-
tures [n ¼ 20] and patients that survived). This could
have contributed to the relatively low failure rate of
implants in irradiated bone.
The percentage of patients rehabilitated with the
help of dental implants placed after ablative surgery
and postoperative radiotherapy varies in the litera-
ture. Reported percentage are between 22% and
91%,9,14,45–50 depending largely on the type of
patients included, the type of reconstruction, the sur-
vival rate of patients and implants, and the length of
the follow-up. In our study where the implants were
placed during ablative surgery, a relatively large
number of the living patients were rehabilitated with
dentures (at T2, 92%; at T3, 83%). No delay or compli-
cations in oncological treatment were seen due to the
placement of the implants at that time. Still, 2
patients refused abutment connection because of the
expected extra burden of abutment connection sur-
gery. Also, from previous data, it was concluded that
many patients refrain from further surgery, including
implant installation, after they survived head and
neck oncology treatment, despite an improvement of
oral functioning that was to be expected postsur-
gery.35 When placing the implants during ablation, a
signiﬁcant time reduction of (pre)prosthetic rehabili-
tation can be achieved. Consequently, a large percent-
age of patients and even patients with a worse
general prognosis can beneﬁt for some time from the
improvements in aesthetics and oral function. Future
studies might identify patients who are less likely to
beneﬁt from implant placement per ablation. Our
study indicates that implant installation during abla-
tive surgery results in a high percentage of rehabili-
tated patients, also after 5 years. From a health
economics point of view, however, the loss of resources
needs further consideration by performing a cost-
effectiveness analysis.
Based on this study, we conclude that the overall
global health and QOL deteriorated in the total group
between 1 and 5 years after placement of the den-
tures, which was due to concurrent comorbidity in a
small number of patients. The global health and QOL
for patients without comorbidity was very high. A
large number of surviving patients could beneﬁt from
an implant-retained mandibular overdenture (83%)
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after 5 years. The oral function and denture satisfac-
tion was high and did not change over time for the 5-
year survivors.
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